Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Clinical and Research Support

General info

Preferred Reporting Items for Systematic Reviews and Meta-Analyses



PRISMA is a minimum set of terms to be used when reporting the conduct of a systematic review (SR). It has recently been revised to reflect changes in systematic review practices and technology.

More information - The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ 2021.

PRISMA is endorsed by many organisations and leading medical journals. Following it's recommendations:

  • enhances the rigour of SR's
  • improves transparency and completeness
  • improves replicability
  • allows readers to interpret results with more confidence


Being aware of reporting recommendations when starting a SR allows prospective authors to make optimal use of their efforts and produce the best possible review.

PRISMA is available in a number of translations.